TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive NCAB Needs Focus, Strong Membership To Better Advise NCI, Chairman Rimer Says September 22, 1995
TCL Archive NCI Director Broder’s Year In Review: Avoid Politics, Stay Focused On Science October 28, 1994